nodes	percent_of_prediction	percent_of_DWPC	metapath
Bismuth Subsalicylate—PTGS2—type 2 diabetes mellitus	0.16	0.529	CbGaD
Bismuth Subsalicylate—ALB—type 2 diabetes mellitus	0.142	0.471	CbGaD
Bismuth Subsalicylate—PTGS1—Pioglitazone—type 2 diabetes mellitus	0.0538	0.115	CbGbCtD
Bismuth Subsalicylate—PTGS1—Chlorpropamide—type 2 diabetes mellitus	0.0538	0.115	CbGbCtD
Bismuth Subsalicylate—PTGS1—Rosiglitazone—type 2 diabetes mellitus	0.0497	0.106	CbGbCtD
Bismuth Subsalicylate—ALB—Gliclazide—type 2 diabetes mellitus	0.0473	0.101	CbGbCtD
Bismuth Subsalicylate—ALB—Repaglinide—type 2 diabetes mellitus	0.0445	0.0948	CbGbCtD
Bismuth Subsalicylate—PTGS1—Nateglinide—type 2 diabetes mellitus	0.0408	0.087	CbGbCtD
Bismuth Subsalicylate—PTGS1—Irbesartan—type 2 diabetes mellitus	0.0391	0.0834	CbGbCtD
Bismuth Subsalicylate—ALB—Rosiglitazone—type 2 diabetes mellitus	0.0371	0.0791	CbGbCtD
Bismuth Subsalicylate—ALB—Valsartan—type 2 diabetes mellitus	0.0328	0.0699	CbGbCtD
Bismuth Subsalicylate—ALB—Nateglinide—type 2 diabetes mellitus	0.0305	0.065	CbGbCtD
Bismuth Subsalicylate—ALB—Glyburide—type 2 diabetes mellitus	0.0206	0.0439	CbGbCtD
Bismuth Subsalicylate—ALB—Losartan—type 2 diabetes mellitus	0.0188	0.0401	CbGbCtD
Bismuth Subsalicylate—PTGS2—leg—type 2 diabetes mellitus	0.00192	0.104	CbGeAlD
Bismuth Subsalicylate—PTGS2—hindlimb—type 2 diabetes mellitus	0.00171	0.0927	CbGeAlD
Bismuth Subsalicylate—TF—retina—type 2 diabetes mellitus	0.00152	0.0824	CbGeAlD
Bismuth Subsalicylate—TF—cardiovascular system—type 2 diabetes mellitus	0.00129	0.0697	CbGeAlD
Bismuth Subsalicylate—TF—kidney—type 2 diabetes mellitus	0.00126	0.0682	CbGeAlD
Bismuth Subsalicylate—TF—pancreas—type 2 diabetes mellitus	0.00125	0.0677	CbGeAlD
Bismuth Subsalicylate—TF—adipose tissue—type 2 diabetes mellitus	0.00114	0.0614	CbGeAlD
Bismuth Subsalicylate—PTGS1—artery—type 2 diabetes mellitus	0.0011	0.0594	CbGeAlD
Bismuth Subsalicylate—PTGS2—artery—type 2 diabetes mellitus	0.00105	0.0568	CbGeAlD
Bismuth Subsalicylate—PTGS1—endothelium—type 2 diabetes mellitus	0.000928	0.0502	CbGeAlD
Bismuth Subsalicylate—PTGS2—endothelium—type 2 diabetes mellitus	0.000887	0.048	CbGeAlD
Bismuth Subsalicylate—TF—liver—type 2 diabetes mellitus	0.000796	0.0431	CbGeAlD
Bismuth Subsalicylate—PTGS2—islet of Langerhans—type 2 diabetes mellitus	0.000505	0.0273	CbGeAlD
Bismuth Subsalicylate—ALB—liver—type 2 diabetes mellitus	0.000414	0.0224	CbGeAlD
Bismuth Subsalicylate—PTGS1—cardiovascular system—type 2 diabetes mellitus	0.000382	0.0207	CbGeAlD
Bismuth Subsalicylate—PTGS1—kidney—type 2 diabetes mellitus	0.000374	0.0202	CbGeAlD
Bismuth Subsalicylate—PTGS2—cardiovascular system—type 2 diabetes mellitus	0.000365	0.0197	CbGeAlD
Bismuth Subsalicylate—PTGS2—kidney—type 2 diabetes mellitus	0.000357	0.0193	CbGeAlD
Bismuth Subsalicylate—PTGS2—pancreas—type 2 diabetes mellitus	0.000355	0.0192	CbGeAlD
Bismuth Subsalicylate—PTGS1—adipose tissue—type 2 diabetes mellitus	0.000337	0.0182	CbGeAlD
Bismuth Subsalicylate—PTGS2—adipose tissue—type 2 diabetes mellitus	0.000322	0.0174	CbGeAlD
Bismuth Subsalicylate—Vomiting—Nateglinide—type 2 diabetes mellitus	0.000275	0.00218	CcSEcCtD
Bismuth Subsalicylate—Hepatitis—Orlistat—type 2 diabetes mellitus	0.000273	0.00217	CcSEcCtD
Bismuth Subsalicylate—Rash—Nateglinide—type 2 diabetes mellitus	0.000272	0.00216	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Glipizide—type 2 diabetes mellitus	0.000272	0.00216	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.000272	0.00216	CcSEcCtD
Bismuth Subsalicylate—Weight increased—Irbesartan—type 2 diabetes mellitus	0.00027	0.00214	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Glipizide—type 2 diabetes mellitus	0.000269	0.00213	CcSEcCtD
Bismuth Subsalicylate—Nausea—Acarbose—type 2 diabetes mellitus	0.000266	0.00211	CcSEcCtD
Bismuth Subsalicylate—Pain—Glipizide—type 2 diabetes mellitus	0.000265	0.0021	CcSEcCtD
Bismuth Subsalicylate—Constipation—Glipizide—type 2 diabetes mellitus	0.000265	0.0021	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Repaglinide—type 2 diabetes mellitus	0.000265	0.0021	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Bromocriptine—type 2 diabetes mellitus	0.000263	0.00208	CcSEcCtD
Bismuth Subsalicylate—Erythema—Gliclazide—type 2 diabetes mellitus	0.000262	0.00208	CcSEcCtD
Bismuth Subsalicylate—Oedema—Bromocriptine—type 2 diabetes mellitus	0.00026	0.00207	CcSEcCtD
Bismuth Subsalicylate—Infection—Bromocriptine—type 2 diabetes mellitus	0.000259	0.00205	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Glimepiride—type 2 diabetes mellitus	0.000257	0.00204	CcSEcCtD
Bismuth Subsalicylate—Nausea—Nateglinide—type 2 diabetes mellitus	0.000257	0.00204	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Sitagliptin—type 2 diabetes mellitus	0.000256	0.00203	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.000256	0.00203	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Glipizide—type 2 diabetes mellitus	0.000255	0.00202	CcSEcCtD
Bismuth Subsalicylate—Weight increased—Losartan—type 2 diabetes mellitus	0.000254	0.00202	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Glimepiride—type 2 diabetes mellitus	0.000254	0.00202	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Sitagliptin—type 2 diabetes mellitus	0.000253	0.00201	CcSEcCtD
Bismuth Subsalicylate—Abdominal pain upper—Ramipril—type 2 diabetes mellitus	0.000253	0.00201	CcSEcCtD
Bismuth Subsalicylate—Hepatitis—Metformin—type 2 diabetes mellitus	0.000252	0.002	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Glimepiride—type 2 diabetes mellitus	0.000251	0.00199	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Sitagliptin—type 2 diabetes mellitus	0.00025	0.00199	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.00025	0.00198	CcSEcCtD
Bismuth Subsalicylate—Epistaxis—Irbesartan—type 2 diabetes mellitus	0.00025	0.00198	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Bromocriptine—type 2 diabetes mellitus	0.000248	0.00197	CcSEcCtD
Bismuth Subsalicylate—Pain—Sitagliptin—type 2 diabetes mellitus	0.000246	0.00195	CcSEcCtD
Bismuth Subsalicylate—Constipation—Sitagliptin—type 2 diabetes mellitus	0.000246	0.00195	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Glipizide—type 2 diabetes mellitus	0.000246	0.00195	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Pioglitazone—type 2 diabetes mellitus	0.000244	0.00194	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.000242	0.00192	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Glyburide—type 2 diabetes mellitus	0.00024	0.00191	CcSEcCtD
Bismuth Subsalicylate—Asthma—Ramipril—type 2 diabetes mellitus	0.00024	0.0019	CcSEcCtD
Bismuth Subsalicylate—Oedema—Glyburide—type 2 diabetes mellitus	0.000238	0.00189	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Glimepiride—type 2 diabetes mellitus	0.000238	0.00189	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000238	0.00189	CcSEcCtD
Bismuth Subsalicylate—Hepatitis—Irbesartan—type 2 diabetes mellitus	0.000238	0.00189	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Sitagliptin—type 2 diabetes mellitus	0.000237	0.00188	CcSEcCtD
Bismuth Subsalicylate—Rash—Repaglinide—type 2 diabetes mellitus	0.000236	0.00187	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Valsartan—type 2 diabetes mellitus	0.000236	0.00187	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000236	0.00187	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.000235	0.00187	CcSEcCtD
Bismuth Subsalicylate—Epistaxis—Losartan—type 2 diabetes mellitus	0.000235	0.00186	CcSEcCtD
Bismuth Subsalicylate—Headache—Repaglinide—type 2 diabetes mellitus	0.000234	0.00186	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000234	0.00185	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Orlistat—type 2 diabetes mellitus	0.000233	0.00185	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Bromocriptine—type 2 diabetes mellitus	0.000232	0.00184	CcSEcCtD
Bismuth Subsalicylate—Abdominal discomfort—Ramipril—type 2 diabetes mellitus	0.00023	0.00182	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Glimepiride—type 2 diabetes mellitus	0.000229	0.00182	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Bromocriptine—type 2 diabetes mellitus	0.000229	0.00182	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.000229	0.00181	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Glyburide—type 2 diabetes mellitus	0.000227	0.0018	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Bromocriptine—type 2 diabetes mellitus	0.000226	0.0018	CcSEcCtD
Bismuth Subsalicylate—PTGS2—liver—type 2 diabetes mellitus	0.000226	0.0122	CbGeAlD
Bismuth Subsalicylate—Hepatitis—Losartan—type 2 diabetes mellitus	0.000224	0.00177	CcSEcCtD
Bismuth Subsalicylate—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000223	0.00177	CcSEcCtD
Bismuth Subsalicylate—Constipation—Bromocriptine—type 2 diabetes mellitus	0.000223	0.00177	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000223	0.00177	CcSEcCtD
Bismuth Subsalicylate—Nausea—Repaglinide—type 2 diabetes mellitus	0.000222	0.00176	CcSEcCtD
Bismuth Subsalicylate—Tinnitus—Irbesartan—type 2 diabetes mellitus	0.000222	0.00176	CcSEcCtD
Bismuth Subsalicylate—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000221	0.00176	CcSEcCtD
Bismuth Subsalicylate—Erythema—Metformin—type 2 diabetes mellitus	0.000219	0.00174	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Glipizide—type 2 diabetes mellitus	0.000219	0.00174	CcSEcCtD
Bismuth Subsalicylate—Weight increased—Ramipril—type 2 diabetes mellitus	0.000218	0.00173	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Gliclazide—type 2 diabetes mellitus	0.000216	0.00171	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Metformin—type 2 diabetes mellitus	0.000215	0.0017	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.000215	0.0017	CcSEcCtD
Bismuth Subsalicylate—Infection—Gliclazide—type 2 diabetes mellitus	0.000212	0.00169	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000212	0.00168	CcSEcCtD
Bismuth Subsalicylate—Erythema multiforme—Losartan—type 2 diabetes mellitus	0.000211	0.00168	CcSEcCtD
Bismuth Subsalicylate—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.00021	0.00167	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.00021	0.00166	CcSEcCtD
Bismuth Subsalicylate—Tinnitus—Losartan—type 2 diabetes mellitus	0.000209	0.00165	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.000207	0.00164	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.000207	0.00164	CcSEcCtD
Bismuth Subsalicylate—Erythema—Irbesartan—type 2 diabetes mellitus	0.000207	0.00164	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000206	0.00163	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Glipizide—type 2 diabetes mellitus	0.000205	0.00162	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000204	0.00162	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000203	0.00161	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Irbesartan—type 2 diabetes mellitus	0.000203	0.00161	CcSEcCtD
Bismuth Subsalicylate—Epistaxis—Ramipril—type 2 diabetes mellitus	0.000201	0.0016	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000198	0.00157	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000197	0.00156	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Glipizide—type 2 diabetes mellitus	0.000197	0.00156	CcSEcCtD
Bismuth Subsalicylate—Oedema—Valsartan—type 2 diabetes mellitus	0.000196	0.00156	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000196	0.00156	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000196	0.00156	CcSEcCtD
Bismuth Subsalicylate—Infection—Valsartan—type 2 diabetes mellitus	0.000195	0.00155	CcSEcCtD
Bismuth Subsalicylate—Rash—Glipizide—type 2 diabetes mellitus	0.000195	0.00155	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000195	0.00155	CcSEcCtD
Bismuth Subsalicylate—Erythema—Losartan—type 2 diabetes mellitus	0.000195	0.00155	CcSEcCtD
Bismuth Subsalicylate—Oedema—Orlistat—type 2 diabetes mellitus	0.000194	0.00154	CcSEcCtD
Bismuth Subsalicylate—Headache—Glipizide—type 2 diabetes mellitus	0.000194	0.00154	CcSEcCtD
Bismuth Subsalicylate—Infection—Orlistat—type 2 diabetes mellitus	0.000193	0.00153	CcSEcCtD
Bismuth Subsalicylate—Hepatitis—Ramipril—type 2 diabetes mellitus	0.000192	0.00152	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000191	0.00152	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Losartan—type 2 diabetes mellitus	0.000191	0.00151	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.00019	0.00151	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Gliclazide—type 2 diabetes mellitus	0.00019	0.00151	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Glyburide—type 2 diabetes mellitus	0.000189	0.0015	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000188	0.00149	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Valsartan—type 2 diabetes mellitus	0.000187	0.00149	CcSEcCtD
Bismuth Subsalicylate—Headache—Pioglitazone—type 2 diabetes mellitus	0.000186	0.00147	CcSEcCtD
Bismuth Subsalicylate—Nausea—Glipizide—type 2 diabetes mellitus	0.000184	0.00146	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000184	0.00146	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000183	0.00145	CcSEcCtD
Bismuth Subsalicylate—Pain—Gliclazide—type 2 diabetes mellitus	0.000183	0.00145	CcSEcCtD
Bismuth Subsalicylate—Constipation—Gliclazide—type 2 diabetes mellitus	0.000183	0.00145	CcSEcCtD
Bismuth Subsalicylate—Rash—Glimepiride—type 2 diabetes mellitus	0.000182	0.00144	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000182	0.00144	CcSEcCtD
Bismuth Subsalicylate—Rash—Sitagliptin—type 2 diabetes mellitus	0.000181	0.00144	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000181	0.00144	CcSEcCtD
Bismuth Subsalicylate—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.000181	0.00144	CcSEcCtD
Bismuth Subsalicylate—Headache—Glimepiride—type 2 diabetes mellitus	0.000181	0.00144	CcSEcCtD
Bismuth Subsalicylate—Headache—Sitagliptin—type 2 diabetes mellitus	0.00018	0.00143	CcSEcCtD
Bismuth Subsalicylate—Oedema—Metformin—type 2 diabetes mellitus	0.000179	0.00142	CcSEcCtD
Bismuth Subsalicylate—Tinnitus—Ramipril—type 2 diabetes mellitus	0.000179	0.00142	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000178	0.00141	CcSEcCtD
Bismuth Subsalicylate—Infection—Metformin—type 2 diabetes mellitus	0.000178	0.00141	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000176	0.0014	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Valsartan—type 2 diabetes mellitus	0.000175	0.00139	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000173	0.00137	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000172	0.00137	CcSEcCtD
Bismuth Subsalicylate—Nausea—Glimepiride—type 2 diabetes mellitus	0.000172	0.00136	CcSEcCtD
Bismuth Subsalicylate—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000171	0.00136	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000171	0.00136	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000171	0.00136	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Metformin—type 2 diabetes mellitus	0.000171	0.00135	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Gliclazide—type 2 diabetes mellitus	0.00017	0.00135	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000169	0.00134	CcSEcCtD
Bismuth Subsalicylate—Oedema—Irbesartan—type 2 diabetes mellitus	0.000169	0.00134	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000169	0.00134	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Glyburide—type 2 diabetes mellitus	0.000168	0.00134	CcSEcCtD
Bismuth Subsalicylate—Constipation—Valsartan—type 2 diabetes mellitus	0.000168	0.00133	CcSEcCtD
Bismuth Subsalicylate—Infection—Irbesartan—type 2 diabetes mellitus	0.000168	0.00133	CcSEcCtD
Bismuth Subsalicylate—Erythema—Ramipril—type 2 diabetes mellitus	0.000167	0.00132	CcSEcCtD
Bismuth Subsalicylate—Pain—Orlistat—type 2 diabetes mellitus	0.000166	0.00132	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000166	0.00131	CcSEcCtD
Bismuth Subsalicylate—Rash—Bromocriptine—type 2 diabetes mellitus	0.000164	0.0013	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000164	0.0013	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000163	0.0013	CcSEcCtD
Bismuth Subsalicylate—Headache—Bromocriptine—type 2 diabetes mellitus	0.000163	0.0013	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000163	0.00129	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000161	0.00128	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Losartan—type 2 diabetes mellitus	0.00016	0.00127	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.00016	0.00127	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Metformin—type 2 diabetes mellitus	0.000159	0.00126	CcSEcCtD
Bismuth Subsalicylate—Oedema—Losartan—type 2 diabetes mellitus	0.000159	0.00126	CcSEcCtD
Bismuth Subsalicylate—Infection—Losartan—type 2 diabetes mellitus	0.000158	0.00125	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000157	0.00125	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Valsartan—type 2 diabetes mellitus	0.000156	0.00124	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000156	0.00123	CcSEcCtD
Bismuth Subsalicylate—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000155	0.00123	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Orlistat—type 2 diabetes mellitus	0.000154	0.00122	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000153	0.00122	CcSEcCtD
Bismuth Subsalicylate—Constipation—Metformin—type 2 diabetes mellitus	0.000153	0.00121	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Losartan—type 2 diabetes mellitus	0.000151	0.0012	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Glyburide—type 2 diabetes mellitus	0.000151	0.0012	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000151	0.0012	CcSEcCtD
Bismuth Subsalicylate—Rash—Glyburide—type 2 diabetes mellitus	0.00015	0.00119	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Irbesartan—type 2 diabetes mellitus	0.00015	0.00119	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Glyburide—type 2 diabetes mellitus	0.00015	0.00119	CcSEcCtD
Bismuth Subsalicylate—Headache—Glyburide—type 2 diabetes mellitus	0.000149	0.00118	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000149	0.00118	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000147	0.00117	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000147	0.00116	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000146	0.00116	CcSEcCtD
Bismuth Subsalicylate—Constipation—Irbesartan—type 2 diabetes mellitus	0.000144	0.00115	CcSEcCtD
Bismuth Subsalicylate—Pain—Irbesartan—type 2 diabetes mellitus	0.000144	0.00115	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Metformin—type 2 diabetes mellitus	0.000142	0.00113	CcSEcCtD
Bismuth Subsalicylate—Nausea—Glyburide—type 2 diabetes mellitus	0.000141	0.00112	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000141	0.00112	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Losartan—type 2 diabetes mellitus	0.000141	0.00112	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Losartan—type 2 diabetes mellitus	0.00014	0.00111	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000139	0.0011	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Valsartan—type 2 diabetes mellitus	0.000139	0.0011	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000138	0.0011	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Ramipril—type 2 diabetes mellitus	0.000137	0.00109	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Orlistat—type 2 diabetes mellitus	0.000137	0.00109	CcSEcCtD
Bismuth Subsalicylate—Oedema—Ramipril—type 2 diabetes mellitus	0.000136	0.00108	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000136	0.00108	CcSEcCtD
Bismuth Subsalicylate—Constipation—Losartan—type 2 diabetes mellitus	0.000136	0.00108	CcSEcCtD
Bismuth Subsalicylate—Pain—Losartan—type 2 diabetes mellitus	0.000136	0.00108	CcSEcCtD
Bismuth Subsalicylate—Rash—Gliclazide—type 2 diabetes mellitus	0.000135	0.00107	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000135	0.00107	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000134	0.00107	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000134	0.00106	CcSEcCtD
Bismuth Subsalicylate—Headache—Gliclazide—type 2 diabetes mellitus	0.000134	0.00106	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000133	0.00106	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000133	0.00105	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000131	0.00104	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Valsartan—type 2 diabetes mellitus	0.00013	0.00103	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Ramipril—type 2 diabetes mellitus	0.00013	0.00103	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Orlistat—type 2 diabetes mellitus	0.000128	0.00102	CcSEcCtD
Bismuth Subsalicylate—Nausea—Gliclazide—type 2 diabetes mellitus	0.000127	0.00101	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Metformin—type 2 diabetes mellitus	0.000127	0.001	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Losartan—type 2 diabetes mellitus	0.000126	0.001	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000126	0.000997	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Valsartan—type 2 diabetes mellitus	0.000125	0.000991	CcSEcCtD
Bismuth Subsalicylate—Rash—Valsartan—type 2 diabetes mellitus	0.000124	0.000983	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000124	0.000982	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Orlistat—type 2 diabetes mellitus	0.000123	0.00098	CcSEcCtD
Bismuth Subsalicylate—Headache—Valsartan—type 2 diabetes mellitus	0.000123	0.000977	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000122	0.000971	CcSEcCtD
Bismuth Subsalicylate—Rash—Orlistat—type 2 diabetes mellitus	0.000122	0.000971	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000122	0.00097	CcSEcCtD
Bismuth Subsalicylate—Headache—Orlistat—type 2 diabetes mellitus	0.000122	0.000965	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Ramipril—type 2 diabetes mellitus	0.000121	0.000961	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.00012	0.000952	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000119	0.000948	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000118	0.00094	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Metformin—type 2 diabetes mellitus	0.000118	0.000939	CcSEcCtD
Bismuth Subsalicylate—Nausea—Valsartan—type 2 diabetes mellitus	0.000117	0.000926	CcSEcCtD
Bismuth Subsalicylate—Constipation—Ramipril—type 2 diabetes mellitus	0.000117	0.000925	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000116	0.000917	CcSEcCtD
Bismuth Subsalicylate—Nausea—Orlistat—type 2 diabetes mellitus	0.000115	0.000915	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Metformin—type 2 diabetes mellitus	0.000114	0.000903	CcSEcCtD
Bismuth Subsalicylate—Rash—Metformin—type 2 diabetes mellitus	0.000113	0.000895	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Metformin—type 2 diabetes mellitus	0.000113	0.000894	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Losartan—type 2 diabetes mellitus	0.000112	0.000892	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000112	0.000891	CcSEcCtD
Bismuth Subsalicylate—Headache—Metformin—type 2 diabetes mellitus	0.000112	0.000889	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000112	0.000886	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000109	0.000863	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Ramipril—type 2 diabetes mellitus	0.000108	0.000859	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000108	0.000855	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000107	0.000852	CcSEcCtD
Bismuth Subsalicylate—Rash—Irbesartan—type 2 diabetes mellitus	0.000106	0.000845	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000106	0.000844	CcSEcCtD
Bismuth Subsalicylate—Nausea—Metformin—type 2 diabetes mellitus	0.000106	0.000843	CcSEcCtD
Bismuth Subsalicylate—Headache—Irbesartan—type 2 diabetes mellitus	0.000106	0.000839	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Losartan—type 2 diabetes mellitus	0.000105	0.000834	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Losartan—type 2 diabetes mellitus	0.000101	0.000802	CcSEcCtD
Bismuth Subsalicylate—Nausea—Irbesartan—type 2 diabetes mellitus	0.0001	0.000796	CcSEcCtD
Bismuth Subsalicylate—Rash—Losartan—type 2 diabetes mellitus	0.0001	0.000795	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Losartan—type 2 diabetes mellitus	0.0001	0.000794	CcSEcCtD
Bismuth Subsalicylate—Headache—Losartan—type 2 diabetes mellitus	9.95e-05	0.00079	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Ramipril—type 2 diabetes mellitus	9.64e-05	0.000765	CcSEcCtD
Bismuth Subsalicylate—Nausea—Losartan—type 2 diabetes mellitus	9.44e-05	0.000749	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Ramipril—type 2 diabetes mellitus	9.32e-05	0.00074	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Ramipril—type 2 diabetes mellitus	9.01e-05	0.000715	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Ramipril—type 2 diabetes mellitus	8.66e-05	0.000687	CcSEcCtD
Bismuth Subsalicylate—Rash—Ramipril—type 2 diabetes mellitus	8.59e-05	0.000682	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Ramipril—type 2 diabetes mellitus	8.58e-05	0.000681	CcSEcCtD
Bismuth Subsalicylate—Headache—Ramipril—type 2 diabetes mellitus	8.53e-05	0.000677	CcSEcCtD
Bismuth Subsalicylate—Nausea—Ramipril—type 2 diabetes mellitus	8.09e-05	0.000642	CcSEcCtD
Bismuth Subsalicylate—PTGS1—Metabolism—CPT1A—type 2 diabetes mellitus	1.48e-05	0.000175	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—MTR—type 2 diabetes mellitus	1.48e-05	0.000175	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CBS—type 2 diabetes mellitus	1.47e-05	0.000174	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—ABCC8—type 2 diabetes mellitus	1.47e-05	0.000174	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—APOB—type 2 diabetes mellitus	1.46e-05	0.000172	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	1.45e-05	0.000172	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—NAMPT—type 2 diabetes mellitus	1.45e-05	0.000171	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	1.44e-05	0.00017	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—LIPC—type 2 diabetes mellitus	1.44e-05	0.00017	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—HBA1—type 2 diabetes mellitus	1.44e-05	0.00017	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—GCK—type 2 diabetes mellitus	1.44e-05	0.00017	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—GCKR—type 2 diabetes mellitus	1.44e-05	0.00017	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—KCNJ11—type 2 diabetes mellitus	1.44e-05	0.00017	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—HSD3B2—type 2 diabetes mellitus	1.44e-05	0.00017	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—LPA—type 2 diabetes mellitus	1.44e-05	0.00017	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—CYP11A1—type 2 diabetes mellitus	1.43e-05	0.000169	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—SLC2A2—type 2 diabetes mellitus	1.43e-05	0.000169	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—SLC5A2—type 2 diabetes mellitus	1.42e-05	0.000168	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—COX2—type 2 diabetes mellitus	1.42e-05	0.000168	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—SLC9A1—type 2 diabetes mellitus	1.4e-05	0.000166	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—MTR—type 2 diabetes mellitus	1.4e-05	0.000166	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—NCOA6—type 2 diabetes mellitus	1.39e-05	0.000165	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	1.39e-05	0.000165	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—CETP—type 2 diabetes mellitus	1.39e-05	0.000164	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	1.38e-05	0.000164	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ALDOB—type 2 diabetes mellitus	1.38e-05	0.000163	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—NAMPT—type 2 diabetes mellitus	1.37e-05	0.000162	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—HSD11B1—type 2 diabetes mellitus	1.37e-05	0.000162	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—UCP2—type 2 diabetes mellitus	1.37e-05	0.000162	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—UCP3—type 2 diabetes mellitus	1.37e-05	0.000162	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—GCK—type 2 diabetes mellitus	1.36e-05	0.000161	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—IAPP—type 2 diabetes mellitus	1.36e-05	0.00016	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	1.34e-05	0.000158	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—SLC9A1—type 2 diabetes mellitus	1.33e-05	0.000157	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	1.33e-05	0.000157	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	1.32e-05	0.000156	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—CD36—type 2 diabetes mellitus	1.32e-05	0.000156	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	1.32e-05	0.000156	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	1.31e-05	0.000155	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—PPP2CA—type 2 diabetes mellitus	1.31e-05	0.000154	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	1.31e-05	0.000154	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	1.3e-05	0.000153	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	1.29e-05	0.000153	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—SREBF1—type 2 diabetes mellitus	1.29e-05	0.000153	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PSMD6—type 2 diabetes mellitus	1.29e-05	0.000153	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—SNAP25—type 2 diabetes mellitus	1.29e-05	0.000153	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PCK1—type 2 diabetes mellitus	1.29e-05	0.000152	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—GLP1R—type 2 diabetes mellitus	1.28e-05	0.000152	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—CTGF—type 2 diabetes mellitus	1.27e-05	0.00015	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	1.27e-05	0.00015	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	1.26e-05	0.000149	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—HMGCR—type 2 diabetes mellitus	1.26e-05	0.000149	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—SRC—type 2 diabetes mellitus	1.25e-05	0.000148	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—HMGA1—type 2 diabetes mellitus	1.25e-05	0.000148	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.24e-05	0.000146	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	1.24e-05	0.000146	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—ADRA2A—type 2 diabetes mellitus	1.23e-05	0.000145	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—PSMD6—type 2 diabetes mellitus	1.22e-05	0.000145	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—SNAP25—type 2 diabetes mellitus	1.22e-05	0.000145	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—VEGFA—type 2 diabetes mellitus	1.22e-05	0.000144	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—MMP1—type 2 diabetes mellitus	1.21e-05	0.000143	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—HK1—type 2 diabetes mellitus	1.2e-05	0.000143	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	1.2e-05	0.000142	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—SLC2A2—type 2 diabetes mellitus	1.2e-05	0.000142	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—CYBA—type 2 diabetes mellitus	1.19e-05	0.00014	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—CYP2E1—type 2 diabetes mellitus	1.18e-05	0.00014	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	1.18e-05	0.000139	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CPT1A—type 2 diabetes mellitus	1.17e-05	0.000139	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—MTR—type 2 diabetes mellitus	1.17e-05	0.000139	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—CALM1—type 2 diabetes mellitus	1.17e-05	0.000138	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—CYP1A2—type 2 diabetes mellitus	1.17e-05	0.000138	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—SLC2A1—type 2 diabetes mellitus	1.17e-05	0.000138	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—KCNJ11—type 2 diabetes mellitus	1.16e-05	0.000138	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—LPA—type 2 diabetes mellitus	1.16e-05	0.000138	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—HSD3B2—type 2 diabetes mellitus	1.16e-05	0.000138	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GCKR—type 2 diabetes mellitus	1.16e-05	0.000138	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—APOA1—type 2 diabetes mellitus	1.15e-05	0.000136	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—NAMPT—type 2 diabetes mellitus	1.15e-05	0.000136	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—CALCA—type 2 diabetes mellitus	1.15e-05	0.000136	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	1.14e-05	0.000135	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—LIPC—type 2 diabetes mellitus	1.14e-05	0.000135	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—HBA1—type 2 diabetes mellitus	1.14e-05	0.000135	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—GCK—type 2 diabetes mellitus	1.14e-05	0.000135	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—CYP3A4—type 2 diabetes mellitus	1.14e-05	0.000135	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CYP11A1—type 2 diabetes mellitus	1.14e-05	0.000134	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.13e-05	0.000134	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—TGFB1—type 2 diabetes mellitus	1.12e-05	0.000133	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—SLC2A4—type 2 diabetes mellitus	1.12e-05	0.000132	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—GCG—type 2 diabetes mellitus	1.12e-05	0.000132	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	1.12e-05	0.000132	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—ALDOB—type 2 diabetes mellitus	1.12e-05	0.000132	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—SLC9A1—type 2 diabetes mellitus	1.12e-05	0.000132	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—SLC2A1—type 2 diabetes mellitus	1.11e-05	0.000131	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CETP—type 2 diabetes mellitus	1.1e-05	0.00013	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—PRKCB—type 2 diabetes mellitus	1.1e-05	0.00013	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—NOS1—type 2 diabetes mellitus	1.09e-05	0.000129	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—NOS2—type 2 diabetes mellitus	1.09e-05	0.000129	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	1.08e-05	0.000128	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	1.08e-05	0.000128	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—TCF7L2—type 2 diabetes mellitus	1.08e-05	0.000128	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	1.06e-05	0.000126	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	1.06e-05	0.000126	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—SLC2A4—type 2 diabetes mellitus	1.06e-05	0.000125	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	1.05e-05	0.000124	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GLP1R—type 2 diabetes mellitus	1.04e-05	0.000123	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	1.03e-05	0.000122	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PSMD6—type 2 diabetes mellitus	1.02e-05	0.000121	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—SNAP25—type 2 diabetes mellitus	1.02e-05	0.000121	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—SREBF1—type 2 diabetes mellitus	1.02e-05	0.000121	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CTGF—type 2 diabetes mellitus	1.01e-05	0.000119	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	9.98e-06	0.000118	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—HMGCR—type 2 diabetes mellitus	9.97e-06	0.000118	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	9.83e-06	0.000116	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ADRA2A—type 2 diabetes mellitus	9.76e-06	0.000115	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—SLC2A2—type 2 diabetes mellitus	9.68e-06	0.000115	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—GNB3—type 2 diabetes mellitus	9.65e-06	0.000114	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PPARGC1A—type 2 diabetes mellitus	9.65e-06	0.000114	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—IGF1—type 2 diabetes mellitus	9.64e-06	0.000114	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—AKT2—type 2 diabetes mellitus	9.63e-06	0.000114	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—HMOX1—type 2 diabetes mellitus	9.6e-06	0.000114	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CPT1A—type 2 diabetes mellitus	9.49e-06	0.000112	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—MTR—type 2 diabetes mellitus	9.49e-06	0.000112	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—CAT—type 2 diabetes mellitus	9.48e-06	0.000112	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CYP2E1—type 2 diabetes mellitus	9.37e-06	0.000111	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—NAMPT—type 2 diabetes mellitus	9.3e-06	0.00011	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—SLC2A1—type 2 diabetes mellitus	9.27e-06	0.00011	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CYP1A2—type 2 diabetes mellitus	9.27e-06	0.00011	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	9.25e-06	0.000109	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—LIPC—type 2 diabetes mellitus	9.24e-06	0.000109	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—HBA1—type 2 diabetes mellitus	9.24e-06	0.000109	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GCK—type 2 diabetes mellitus	9.24e-06	0.000109	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—TGFBR2—type 2 diabetes mellitus	9.23e-06	0.000109	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—APOB—type 2 diabetes mellitus	9.2e-06	0.000109	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CYP11A1—type 2 diabetes mellitus	9.19e-06	0.000109	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—SERPINE1—type 2 diabetes mellitus	9.15e-06	0.000108	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CYP3A4—type 2 diabetes mellitus	9.04e-06	0.000107	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—SLC9A1—type 2 diabetes mellitus	9.02e-06	0.000107	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—GSTM1—type 2 diabetes mellitus	8.95e-06	0.000106	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—CDKN2B—type 2 diabetes mellitus	8.94e-06	0.000106	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CETP—type 2 diabetes mellitus	8.92e-06	0.000105	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—SLC2A4—type 2 diabetes mellitus	8.89e-06	0.000105	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—GCG—type 2 diabetes mellitus	8.89e-06	0.000105	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—LPL—type 2 diabetes mellitus	8.78e-06	0.000104	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—NOS3—type 2 diabetes mellitus	8.74e-06	0.000103	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—PIK3R1—type 2 diabetes mellitus	8.74e-06	0.000103	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—APOB—type 2 diabetes mellitus	8.72e-06	0.000103	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—ADCY5—type 2 diabetes mellitus	8.6e-06	0.000102	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—GPX1—type 2 diabetes mellitus	8.57e-06	0.000101	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—CD36—type 2 diabetes mellitus	8.35e-06	9.87e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—LPL—type 2 diabetes mellitus	8.33e-06	9.85e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PSMD6—type 2 diabetes mellitus	8.29e-06	9.81e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—SREBF1—type 2 diabetes mellitus	8.29e-06	9.81e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—SNAP25—type 2 diabetes mellitus	8.29e-06	9.81e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PPP2CA—type 2 diabetes mellitus	8.24e-06	9.75e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—ADCY5—type 2 diabetes mellitus	8.15e-06	9.64e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CTGF—type 2 diabetes mellitus	8.14e-06	9.63e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—HMGCR—type 2 diabetes mellitus	8.07e-06	9.54e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	7.95e-06	9.41e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—MTHFR—type 2 diabetes mellitus	7.91e-06	9.35e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—ADRA2A—type 2 diabetes mellitus	7.89e-06	9.34e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—PPP2CA—type 2 diabetes mellitus	7.81e-06	9.24e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—AKT1—type 2 diabetes mellitus	7.79e-06	9.22e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PPARA—type 2 diabetes mellitus	7.76e-06	9.18e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—CCR5—type 2 diabetes mellitus	7.67e-06	9.07e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PPARGC1A—type 2 diabetes mellitus	7.66e-06	9.06e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—GNB3—type 2 diabetes mellitus	7.66e-06	9.06e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—HMOX1—type 2 diabetes mellitus	7.62e-06	9.02e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CYP2E1—type 2 diabetes mellitus	7.58e-06	8.97e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CAT—type 2 diabetes mellitus	7.52e-06	8.9e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—AGT—type 2 diabetes mellitus	7.51e-06	8.89e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CYP1A2—type 2 diabetes mellitus	7.5e-06	8.87e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—SLC2A1—type 2 diabetes mellitus	7.5e-06	8.87e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—MTHFR—type 2 diabetes mellitus	7.5e-06	8.87e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—CALM1—type 2 diabetes mellitus	7.39e-06	8.74e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—APOE—type 2 diabetes mellitus	7.36e-06	8.71e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CYP3A4—type 2 diabetes mellitus	7.31e-06	8.65e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—APOB—type 2 diabetes mellitus	7.3e-06	8.64e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—APOA1—type 2 diabetes mellitus	7.28e-06	8.61e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	7.28e-06	8.6e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—SLC2A4—type 2 diabetes mellitus	7.19e-06	8.5e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GCG—type 2 diabetes mellitus	7.19e-06	8.5e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—HIF1A—type 2 diabetes mellitus	7.15e-06	8.46e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—IRS2—type 2 diabetes mellitus	7.13e-06	8.43e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—GSTM1—type 2 diabetes mellitus	7.1e-06	8.4e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—CALM1—type 2 diabetes mellitus	7e-06	8.28e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—APOE—type 2 diabetes mellitus	6.98e-06	8.25e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—LPL—type 2 diabetes mellitus	6.97e-06	8.25e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—APOA1—type 2 diabetes mellitus	6.9e-06	8.16e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ADCY5—type 2 diabetes mellitus	6.83e-06	8.07e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—GPX1—type 2 diabetes mellitus	6.8e-06	8.05e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CD36—type 2 diabetes mellitus	6.62e-06	7.84e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PPP2CA—type 2 diabetes mellitus	6.54e-06	7.74e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—NOS2—type 2 diabetes mellitus	6.5e-06	7.69e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—SRC—type 2 diabetes mellitus	6.46e-06	7.64e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PPARG—type 2 diabetes mellitus	6.41e-06	7.58e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—VEGFA—type 2 diabetes mellitus	6.29e-06	7.44e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—INS—type 2 diabetes mellitus	6.29e-06	7.44e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—MTHFR—type 2 diabetes mellitus	6.28e-06	7.43e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—IRS1—type 2 diabetes mellitus	6.23e-06	7.36e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GNB3—type 2 diabetes mellitus	6.2e-06	7.33e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PPARGC1A—type 2 diabetes mellitus	6.2e-06	7.33e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—HMOX1—type 2 diabetes mellitus	6.17e-06	7.29e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PPARA—type 2 diabetes mellitus	6.16e-06	7.28e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CAT—type 2 diabetes mellitus	6.09e-06	7.2e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—AGT—type 2 diabetes mellitus	5.96e-06	7.06e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—INS—type 2 diabetes mellitus	5.96e-06	7.05e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—APOB—type 2 diabetes mellitus	5.91e-06	6.99e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CALM1—type 2 diabetes mellitus	5.87e-06	6.94e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—APOE—type 2 diabetes mellitus	5.84e-06	6.91e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—APOA1—type 2 diabetes mellitus	5.78e-06	6.83e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—TGFB1—type 2 diabetes mellitus	5.78e-06	6.83e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—ALB—type 2 diabetes mellitus	5.77e-06	6.82e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—AKT2—type 2 diabetes mellitus	5.76e-06	6.82e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GSTM1—type 2 diabetes mellitus	5.75e-06	6.8e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—LPL—type 2 diabetes mellitus	5.64e-06	6.67e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—ADCY5—type 2 diabetes mellitus	5.52e-06	6.53e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—NOS3—type 2 diabetes mellitus	5.52e-06	6.52e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PIK3R1—type 2 diabetes mellitus	5.52e-06	6.52e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GPX1—type 2 diabetes mellitus	5.5e-06	6.51e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—SERPINE1—type 2 diabetes mellitus	5.48e-06	6.48e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CD36—type 2 diabetes mellitus	5.36e-06	6.34e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PPP2CA—type 2 diabetes mellitus	5.29e-06	6.26e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—PIK3R1—type 2 diabetes mellitus	5.23e-06	6.18e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—NOS3—type 2 diabetes mellitus	5.23e-06	6.18e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PPARG—type 2 diabetes mellitus	5.09e-06	6.02e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—MTHFR—type 2 diabetes mellitus	5.08e-06	6.01e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PTGS2—type 2 diabetes mellitus	5.04e-06	5.97e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—INS—type 2 diabetes mellitus	4.99e-06	5.91e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PPARA—type 2 diabetes mellitus	4.98e-06	5.89e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—AGT—type 2 diabetes mellitus	4.83e-06	5.71e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CALM1—type 2 diabetes mellitus	4.75e-06	5.61e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—APOE—type 2 diabetes mellitus	4.73e-06	5.59e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—APOA1—type 2 diabetes mellitus	4.67e-06	5.53e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ALB—type 2 diabetes mellitus	4.58e-06	5.41e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PIK3R1—type 2 diabetes mellitus	4.38e-06	5.18e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—NOS3—type 2 diabetes mellitus	4.38e-06	5.18e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PPARG—type 2 diabetes mellitus	4.12e-06	4.87e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—INS—type 2 diabetes mellitus	4.04e-06	4.78e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—AKT1—type 2 diabetes mellitus	4.02e-06	4.75e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—SRC—type 2 diabetes mellitus	3.87e-06	4.57e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PIK3R1—type 2 diabetes mellitus	3.54e-06	4.19e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—NOS3—type 2 diabetes mellitus	3.54e-06	4.19e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—TGFB1—type 2 diabetes mellitus	3.46e-06	4.09e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—EGFR—type 2 diabetes mellitus	3.39e-06	4.01e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PTGS2—type 2 diabetes mellitus	3.24e-06	3.83e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—IL6—type 2 diabetes mellitus	2.61e-06	3.08e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—AKT1—type 2 diabetes mellitus	2.54e-06	3e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—AKT1—type 2 diabetes mellitus	2.4e-06	2.84e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—AKT1—type 2 diabetes mellitus	2.01e-06	2.38e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—AKT1—type 2 diabetes mellitus	1.63e-06	1.93e-05	CbGpPWpGaD
